Stephen Wilton
Director/Board Member bei BIOSYENT INC.
Vermögen: 16 679 $ am 31.03.2024
Profil
Stephen Wilton is an Independent Director at BioSyent, Inc. since 2014.
Prior to this, he worked as an Executive Director-Business Development at AstraZeneca Pharmaceuticals LP from 1993 to 2010 and as a Vice President-Pharmacy Affairs at The Canadian Association of Chain Drug Stores from 2011 to 2012.
He completed his undergraduate degree at the University of Toronto and his MBA at The Schulich School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOSYENT INC.
0,02% | 27.03.2024 | 2 600 ( 0,02% ) | 16 679 $ | 31.03.2024 |
Aktive Positionen von Stephen Wilton
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOSYENT INC. | Director/Board Member | 16.01.2014 |
Ehemalige bekannte Positionen von Stephen Wilton
| Unternehmen | Position | Ende |
|---|---|---|
| The Canadian Association of Chain Drug Stores | Corporate Officer/Principal | 01.01.2012 |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | General Counsel | - |
Ausbildung von Stephen Wilton
| University of Toronto | Undergraduate Degree |
| The Schulich School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOSYENT INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
| The Canadian Association of Chain Drug Stores |
